Clinical Context Shapes the Relationship between Genomic Alterations and Response to AR Inhibitors and Chemotherapy in Metastatic Prostate Cancer.
Shah K, Secrest MH, Zhou W, Wang S, Canter D, Zhang Y, Jin D, Sokol E, Nowicka M, Ang Houle A, Metcalfe C, Gendreau S, Schröder C, Wongchenko M, Attard G.
Shah K, et al. Among authors: secrest mh.
Clin Cancer Res. 2025 Jul 1;31(13):2824-2838. doi: 10.1158/1078-0432.CCR-24-1812.
Clin Cancer Res. 2025.
PMID: 40227200
Free PMC article.